Table 1.
Adult (%) | Pediatric (%) | |
---|---|---|
Stage: L1 | 57 (48) | 24 (22%) |
Median age (range) | 48 (18–77) | 5.5 (3–15) |
Histology | ||
Ganglioneuroblastoma | 6 (11) | 6 (25) |
Neuroblastoma | 51 (89) | 18 (75) |
Primary location | ||
Bones, skeletal system | 1 (2) | 1 (4) |
Central nervous system | 1 (2) | 1 (4) |
Chest cavity viscera | 2 (4) | 4 (17) |
Head and neck | 46 (81) | 3 (12) |
Soft tissue | 2 (4) | 8 (33) |
Urinary tract | 5 (9) | 7 (29) |
Stage: L2 | 44 (37) | 12 (11) |
Median age (range) | 51.5 (20–81) | 5.5 (3–10) |
Histology | ||
Ganglioneuroblastoma | 2 (5) | 3 (25) |
Neuroblastoma | 42 (95) | 9 (75) |
Primary location | ||
Central nervous system | 3 (7) | 2 (17) |
Chest cavity viscera | 2 (5) | 1 (8) |
Head and neck | 32 (73) | 1 (8) |
Soft tissue | 3 (7) | 5 (42) |
Urinary tract | 4 (9) | 3 (25) |
Stage: M | 17 (14) | 74 (67) |
Median age (range) | 29 (19–75) | 5 (3–16) |
Histology | ||
Ganglioneuroblastoma | 1 (16) | 4 (5) |
Neuroblastoma | 16 (94) | 70 (95) |
Primary location | ||
Abdominal cavity viscera | 2 (12) | 1 (1) |
Central nervous system | 0 | 1 (1) |
Chest cavity viscera | 1 (6) | 5 (7) |
Male genital system | 1 (6) | 0 |
Head and neck | 4 (24) | 2 (3) |
Metastatic cancer | 1 (6) | 1 (1) |
Soft tissue | 4 (24) | 25 (34) |
Genitourinary tract∗ | 4 (24) | 39 (53) |
*Includes adrenal primary.